• Portola Pharmaceuticals R&D Exec to Retire contractpharma
    April 26, 2019
    Portola Pharmaceuticals, Inc.: Dr. John Curnutte, M.D., Ph.D., executive vice president and head of R&D, will retire on May 17, 2019, after more than eight years of service.
  • Eli Lilly’s President of Oncology to retire pharmafile
    June 07, 2018
    Just as it ramps up its cancer-fighting efforts, Eli Lilly has revealed that its Senior Vice President and President of Lilly Oncology Sue Mahony is set to retire from her role, effective 31 August.
PharmaSources Customer Service